| Patent application number | Description | Published |
|---|
| 20080255160 | MAPK/ERK KINASE INHIBITORS - Compounds of the following formula are provided for use with MEK: | 10-16-2008 |
| 20080312307 | MAPK/ERK KINASE INHIBITORS - Compounds are provided for inhibition of MEK that comprise: | 12-18-2008 |
| 20090118324 | MAPK/ERK KINASE INHIBITORS - Compounds are provided for use with MEK that comprise: | 05-07-2009 |
| 20090124595 | MAPK/ERK KINASE INHIBITORS - Compounds of the following formula are provided for use with MEK: | 05-14-2009 |
| 20090156557 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of: | 06-18-2009 |
| 20090247554 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise (I), (II), (III), (IV): wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds. | 10-01-2009 |
| 20100029941 | PREPARATION OF (R)-3-AMINOPIPERIDINE DIHYDROCHLORIDE - Described herein are methods for making chiral derivatives of 3-aminopiperidine, including the production of such derivatives in quantities exceeding 1 kilogram. The chiral 3-aminopiperidine derivatives include (R)-3-aminopiperidine derivatives which may be used to synthesize inhibitors of Dipeptidyl Peptidase IV. (R)-3-Aminopiperidine dihydrochloride is prepared by reducing (R)-3-aminopiperidin-2-one hydrochloride with lithium aluminum hydride. The preparation of (R)-3-aminopiperidin-2-one hydrochloride starting from (R)-methyl-2,5-diaminopentanoate dihydrochloride or (R)-2,5-diaminopentanoic acid hydrochloride is also described. | 02-04-2010 |
| 20100063054 | cMET INHIBITORS - Compounds of the following formula are provided for use with cMET: | 03-11-2010 |
| 20100120717 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture in comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds. | 05-13-2010 |
| 20100130518 | MAPK/ERK KINASE INHIBITORS - Compounds of the following formula are provided for use with MEK (I): wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds. | 05-27-2010 |
| 20100160633 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of: | 06-24-2010 |
| 20100190816 | KINASE INHIBITORS - Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound selected from the group consisting of: | 07-29-2010 |
| 20100216765 | KINASE INHIBITORS - Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of: | 08-26-2010 |
| 20110087022 | Dipeptidyl Peptidase Inhibitors - Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a member selected from the group consisting of: | 04-14-2011 |
| 20110136780 | DIHYDROPYRROLONAPHTYRIDINONE COMPOUNDS AS INHIBITORS OF JAK - Disclosed are JAK inhibitors of formula I | 06-09-2011 |
